- Home
- LCNB vs XBIT Comparison
LCNB vs XBIT Comparison
Compare LCNB & XBIT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- LCNB
- XBIT
- Stock Information
- Founded
- LCNB 1877
- XBIT 2005
- Country
- LCNB United States
- XBIT United States
- Employees
- LCNB N/A
- XBIT N/A
- Industry
- LCNB Major Banks
- XBIT Pharmaceuticals and Biotechnology
- Sector
- LCNB Finance
- XBIT Health Care
- Exchange
- LCNB Nasdaq
- XBIT Nasdaq
- Market Cap
- LCNB 216.4M
- XBIT 194.5M
- IPO Year
- LCNB N/A
- XBIT 2015
- Fundamental
- Price
- LCNB $14.60
- XBIT $2.99
- Analyst Decision
- LCNB
- XBIT
- Analyst Count
- LCNB 0
- XBIT 0
- Target Price
- LCNB N/A
- XBIT N/A
- AVG Volume (30 Days)
- LCNB 18.7K
- XBIT 54.9K
- Earning Date
- LCNB 01-30-2025
- XBIT 03-14-2025
- Dividend Yield
- LCNB 6.03%
- XBIT N/A
- EPS Growth
- LCNB N/A
- XBIT N/A
- EPS
- LCNB 0.97
- XBIT N/A
- Revenue
- LCNB $79,237,000.00
- XBIT N/A
- Revenue This Year
- LCNB N/A
- XBIT N/A
- Revenue Next Year
- LCNB $7.21
- XBIT N/A
- P/E Ratio
- LCNB $15.05
- XBIT N/A
- Revenue Growth
- LCNB 13.71
- XBIT N/A
- 52 Week Low
- LCNB $12.42
- XBIT $2.99
- 52 Week High
- LCNB $17.92
- XBIT $9.96
- Technical
- Relative Strength Index (RSI)
- LCNB 34.35
- XBIT 31.96
- Support Level
- LCNB $15.26
- XBIT $3.03
- Resistance Level
- LCNB $15.68
- XBIT $3.32
- Average True Range (ATR)
- LCNB 0.38
- XBIT 0.19
- MACD
- LCNB -0.08
- XBIT 0.04
- Stochastic Oscillator
- LCNB 0.00
- XBIT 0.00
About LCNB LCNB Corporation
LCNB Corp operates within the financial sector in the United States. As the holding company of the National Bank, it conducts the business of providing commercial and personal banking services. Its suite of banking products includes commercial and industrial loans, consumer loans, safe deposit boxes, night depositories, cashier's checks, utility bill collections, and notary public service. Besides, it provides the avenue of United States Treasury notes, the United States agency notes, certificates of deposit, and equity securities.
About XBIT XBiotech Inc.
XBiotech Inc is a United States-based clinical-stage biopharmaceutical company. It is engaged in discovering and developing True Human (antibody technology) monoclonal antibodies for treating a variety of diseases. The company focuses on developing Anti-IL-1 a therapeutic antibody as a treatment for cancer. Geographically, all of its operations are in the United States.